Effect of Restoration of Sinus Rhythm by Extensive Antiarrhythmic Drugs in Predicting Results of Catheter Ablation of Persistent Atrial Fibrillation

American Journal of Cardiology

Volumn 106, Issue 1, 2010, Pages 62-68

  Igarashi, Miyako ^a   Tada, Hiroshi ^a   Sekiguchi, Yukio ^a   Yamasaki, Hiro ^a   Arimoto, Takanori ^a   Kuroki, Kenji ^a   Machino, Takeshi ^a   Murakoshi, Nobuyuki ^a   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; APRINDINE; BEPRIDIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; FLECAINIDE; PILSICAINIDE; PROPAFENONE;

ADULT; AGED; ARTICLE; BRADYCARDIA; CATHETER ABLATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY VEIN; QT PROLONGATION; RECURRENT DISEASE; SINUS RHYTHM; TORSADE DES POINTES;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY VEINS; TREATMENT OUTCOME;

EID: 77953609723     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.02.016     Document Type: Article

References (29)

1. Hagens V.E., Van Veldhuisen D.J., Kamp O., Rienstra M., Bosker H.A., Veeger N.J., Tijssen J.G., Crijns H.J., Van Gelder I.C., and RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm 2 (2005) 19-24
2. Reant P., Lafitte S., Jais P., Serri K., Weerasooriya R., Hocini M., Pillois X., Clementy J., Haissaguerre M., and Roudaut R. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation 112 (2005) 2896-2903
3. Lemola K., Desjardins B., Sneider M., Case I., Chugh A., Good E., Han J., Tamirisa K., Tsemo A., Reich S., Tschopp D., Igic P., Elmouchi D., Bogun F., Pelosi Jr. F., Kazerooni E., Morady F., and Oral H. Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm 2 (2005) 923-928
4. Chen M.S., Marrouche N.F., Khaykin Y., Gillinov A.M., Wazni O., Martin D.O., Rossillo A., Verma A., Cummings J., Erciyes D., Saad E., Bhargava M., Bash D., Schweikert R., Burkhardt D., Williams-Andrews M., Perez-Lugones A., Abdul-Karim A., Saliba W., and Natale A. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 43 (2004) 1004-1009
5. Shin S.H., Park M.Y., Oh W.J., Hong S.J., Pak H.N., Song W.H., Lim D.S., Kim Y.H., and Shim W.J. Left atrial volume is a predictor of atrial fibrillation recurrence after catheter ablation. J Am Soc Echocardiogr 21 (2008) 697-702
6. Koyama T., Sekiguchi Y., Tada H., Arimoto T., Yamasaki H., Kuroki K., Machino T., Tajiri K., Zhu X.D., Kanemoto M., Sugiyasu A., Kuga K., and Aonuma K. Comparison of characteristics and significance of immediate-vs-early-vs-non-recurrence of atrial fibrillation after catheter ablation. Am J Cardiol 103 (2009) 1249-1254
7. Oral H., Knight B.P., Ozaydin M., Tada H., Chugh A., Hassan S., Scharf C., Lai S.W., Greenstein R., Pelosi Jr. F., Strickberger S.A., and Morady F. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 40 (2002) 100-104
8. Tsuji T., Imagawa K., Masuda H., Haraikawa M., Shibata K., Kono M., Inouye K., and Uchida K. Stabilization of human natriuretic peptide in blood samples. Clin Chem 40 (1994) 672-673
9. Naccarelli G.V., Wolbrette D.L., Khan M., Bhatta L., Hynes J., Samii S., and Luck J. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 91 (2003) 15D-26D
10. Lafuente-Lafuente C., Mouly S., Longas-Tejero M.A., Mahe I., and Bergmann J.F. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med 166 (2006) 719-728
11. Prystowsky E.N., Freeland S., Branyas N.A., Rardon D.P., Fogel R.I., Padanilam B.J., and Rippy J.S. Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. J Cardiovasc Electrophysiol 14 Suppl (2003) S287-S290
12. Singh S., Zoble R.G., Yellen L., Brodsky M.A., Feld G.K., Berk M., and Billing Jr. C.B. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102 (2000) 2385-2390
13. Nakazato Y., Yasuda M., Sasaki A., Iida Y., Kawano Y., Nakazato K., Tokano T., Mineda Y., Sumiyoshi M., Nakata Y., and Daida H. Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation. Circ J 69 (2005) 44-48
14. Yamashita T., Ogawa S., Sato T., Aizawa Y., Atarashi H., Fujiki A., Inoue H., Ito M., Katoh T., Kobayashi Y., Koretsune Y., Kumagai K., Niwano S., Okazaki O., Okumura K., Saku K., Tanabe T., Origasa H., and J-BAF Investigators. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled, double-blind study (J-BAF Study). Circ J 73 (2009) 1020-1027
15. Perelman M.S., McKenna W.J., Rowland E., and Krikler D.M. A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation. Br Heart J 58 (1987) 339-344
16. Casaclang-Verzosa G., Gersh B.J., and Tsang T.S. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51 (2008) 1-11
17. Fujiki A., Sakamoto T., Iwamoto J., Nishida K., Nagasawa H., Mizumaki K., and Inoue H. Pharmacological cardioversion of persistent atrial fibrillation with and without a history of drug-resistant paroxysmal atrial fibrillation. Circ J 70 (2006) 1138-1141
18. Vorperian V.R., Havighurst T.C., Miller S., and January C.T. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30 (1997) 791-798
19. Terasawa T., Balk E.M., Chung M., Garlitski A.C., Alsheikh-Ali A.A., Lau J., and Ip S. Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation. Ann Intern Med 151 (2009) 191-202
20. Fiala M., Chovancik J., Nevralova R., Neuwirth R., Jiravsky O., Januska J., and Branny M. Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation. Pacing Clin Electrophysiol 31 (2008) 985-997
21. Elayi C.S., Verma A., Di Biase L., Ching C.K., Patel D., Barrett C., Martin D., Rong B., Fahmy T.S., Khaykin Y., Hongo R., Hao S., Pelargonio G., Dello Russo A., Casella M., Santarelli P., Potenza D., Fanelli R., Massaro R., Arruda M., Schweikert R.A., and Natale A. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm 5 (2008) 1658-1664
22. Schoonderwoerd B.A., Van Gelder I.C., Van Veldhuisen D.J., Van den Berg M.P., and Crijns H.J. Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation. Prog Cardiovasc Dis 48 (2005) 153-168
23. Verma A., Wazni O.M., Marrouche N.F., Martin D.O., Kilicaslan F., Minor S., Schweikert R.A., Saliba W., Cummings J., Burkhardt J.D., Bhargava M., Belden W.A., Abdul-Karim A., and Natale A. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol 45 (2005) 285-292
24. Park J.H., Pak H.N., Choi E.J., Jang J.K., Kim S.K., Choi D.H., Choi J.I., Hwang C., and Kim Y.H. The relationship between endocardial voltage and regional volume in electroanatomical remodeled left atria in patients with atrial fibrillation: comparison of three-dimensional computed tomographic images and voltage mapping. J Cardiovasc Electrophysiol 20 (2009) 1349-1356
25. Chang S.L., Tai C.T., Lin Y.J., Wongcharoen W., Lo L.W., Tuan T.C., Udyavar A.R., Chang S.H., Tsao H.M., Hsieh M.H., Hu Y.F., Chen Y.J., and Chen S.A. Biatrial substrate properties in patients with atrial fibrillation. J Cardiovasc Electrophysiol 18 (2007) 1134-1139
26. Burstein B., and Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51 (2008) 802-809
27. Smelley M.P., and Knight B.P. Approaches to catheter ablation of persistent atrial fibrillation. Heart Rhythm 6 Suppl (2009) S33-S38
28. Oral H., Chugh A., Yoshida K., Sarrazin J.F., Kuhne M., Crawford T., Chalfoun N., Wells D., Boonyapisit W., Veerareddy S., Billakanty S., Wong W.S., Good E., Jongnarangsin K., Pelosi Jr. F., Bogun F., and Morady F. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol 53 (2009) 782-789
29. O'Neill M.D., Wright M., Knecht S., Jais P., Hocini M., Takahashi Y., Jonsson A., Sacher F., Matsuo S., Lim K.T., Arantes L., Derval N., Lellouche N., Nault I., Bordachar P., Clementy J., and Haissaguerre M. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J 30 (2009) 1105-1112